PeerVoice

Less than 2 weeks to #ESPE2024 in #Liverpool, UK. Be sure to mark #PeerVoice CME-accredited satellite symposium on Type 1 Diabetes: Rationales and Roadmaps for Early Detection and Proactive Intervention chaired by Olga Prof. Dr. Kordonouri in your agenda? ⬇ For more information ⬇ https://lnkd.in/eeVXFf7i 📅 Date: Monday, 18 November 2024 ⏰ Time: 13:05 - 14:05 PM GMT 📍ACC Liverpool, HALL 1

Watch now: https://lnkd.in/eVRt7tzt Join a nephrology expert in this CME-accredited congress spotlight from San Diego in which she highlights recently presented outcomes from several trials for C3 glomerulopathy (C3G) and immune complex-mediated membranoproliferative glomerulonephritis (IC-MPGN). The expert also comments on what these findings may mean for future clinical practice, given that there have been no universally effective treatments for primary forms of C3G and IC-MPGN. #PeerVoice #meded #nephrology #glomerulardisease #C3G #IC-MPGN

Watch now: https://lnkd.in/enYUeSXQ Congress spotlight from San Diego: Join Richard Lafayette and Jonathan Barratt, in this CME-accredited rapid round-up in which they highlight the key outcomes recently presented for immunoglobulin A nephropathy (IgAN) and how the evidence may impact the future of IgAN management. #PeerVoice #meded #nephrology #IgAN #kidneydisease

𝐃𝐨 𝐲𝐨𝐮 𝐥𝐨𝐯𝐞 𝐝𝐚𝐭𝐚? ❤️ I know I do! When looking back at this picture from over nine years ago, I still feel the same enthusiasm—if not more. Around the time I took this picture, I learned one of the most valuable lessons: Data is more than reports to be built or stories to be told. It is also 𝐚 𝐩𝐨𝐰𝐞𝐫𝐟𝐮𝐥 𝐭𝐨𝐨𝐥 𝐭𝐡𝐚𝐭 𝐞𝐚𝐜𝐡 𝐨𝐟 𝐮𝐬—𝐝𝐚𝐭𝐚 𝐠𝐞𝐞𝐤𝐬 𝐨𝐫 𝐧𝐨𝐭—𝐜𝐚𝐧 𝐮𝐬𝐞 𝐭𝐨 𝐥𝐞𝐚𝐫𝐧 𝐚𝐧𝐝 𝐢𝐦𝐩𝐫𝐨𝐯𝐞. But to unlock its empowering potential for everyone, we need to first make it 𝐚𝐜𝐭𝐢𝐨𝐧𝐚𝐛𝐥𝐞 𝐚𝐧𝐝 𝐚𝐜𝐜𝐞𝐬𝐬𝐢𝐛𝐥𝐞. 🔓 If you're heading to #17ECF, come join our workshop, "𝐌𝐚𝐱𝐢𝐦𝐢𝐬𝐢𝐧𝐠 𝐭𝐡𝐞 𝐩𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥 𝐨𝐟 𝐨𝐮𝐭𝐜𝐨𝐦𝐞𝐬 𝐯𝐢𝐚 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲: 𝐏𝐫𝐞𝐩𝐚𝐫𝐢𝐧𝐠 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐰𝐡𝐢𝐥𝐬𝐭 𝐞𝐦𝐛𝐫𝐚𝐜𝐢𝐧𝐠 𝐭𝐡𝐞 𝐩𝐨𝐰𝐞𝐫 𝐨𝐟 𝐧𝐨𝐰." Together, we will explore whether—and how—technology can open the door to an exciting new world where 𝐂𝐌𝐄 𝐨𝐮𝐭𝐜𝐨𝐦𝐞𝐬 𝐝𝐚𝐭𝐚 𝐢𝐬 𝐦𝐨𝐫𝐞 𝐚𝐜𝐭𝐢𝐨𝐧𝐚𝐛𝐥𝐞 𝐚𝐧𝐝 𝐚𝐜𝐜𝐞𝐬𝐬𝐢𝐛𝐥𝐞 𝐭𝐡𝐚𝐧 𝐞𝐯𝐞𝐫 𝐛𝐞𝐟𝐨𝐫𝐞. Looking for a 𝐫𝐞𝐚𝐥-𝐰𝐨𝐫𝐥𝐝 𝐞𝐱𝐚𝐦𝐩𝐥𝐞 of how outcomes drive actionable insights? You also won’t want to miss our poster presentation, “𝐓𝐨𝐰𝐚𝐫𝐝𝐬 𝐚𝐧 𝐞𝐱𝐩𝐚𝐧𝐝𝐞𝐝 𝐥𝐞𝐯𝐞𝐥 5 𝐨𝐮𝐭𝐜𝐨𝐦𝐞𝐬 𝐞𝐯𝐚𝐥𝐮𝐚𝐭𝐢𝐨𝐧 𝐟𝐫𝐚𝐦𝐞𝐰𝐨𝐫𝐤: 𝐔𝐧𝐩𝐚𝐜𝐤𝐢𝐧𝐠 𝐭𝐡𝐞 𝐜𝐨𝐦𝐩𝐥𝐞𝐱𝐢𝐭𝐲 𝐨𝐟 𝐜𝐥𝐢𝐧𝐢𝐜𝐢𝐚𝐧 𝐩𝐞𝐫𝐟𝐨𝐫𝐦𝐚𝐧𝐜𝐞.” Our journey to 𝐞𝐦𝐩𝐨𝐰𝐞𝐫𝐢𝐧𝐠 𝐨𝐮𝐭𝐜𝐨𝐦𝐞𝐬 has already begun. Will you join us along the way?👣🚶♂️🚶♀️ #CMECPD #ActionableOutcomes #EmpowerThroughData #Technology #PeerVoice

Watch Now:  https://lnkd.in/eN2hpiE9 In this two-part activity, Professor Jonathan Barratt and a patient with immunoglobulin A nephropathy discuss the impact of living with IgAN and the evolving therapeutic landscape for this condition. #PeerVoice #Nephrology #IgAN #ImmunoglobulinAnephropathy #nephropathy #CKD #CME

Are you heading to the 17th European CME Forum 6 - 8th November? If yes, then don't miss these two workshops hosted by Pan Chen, Huw Williams, PhD, James Bannister and James White focusing on the role of AI in CME and maximising the potential of outcomes via technology. These sessions will be held on Wednesday 6th November at 4pm. #CMEforum #AI #Outcomes #Technology #CME #MedEd

Watch Now: https://lnkd.in/e_CZ4vcv Did you miss the PeerVoice live event on prostate cancer and the existing and emerging roles for radiopharmaceuticals? Watch a replay in which experts Neal Shore, MD, FACS; Bertrand Tombal, MD, PhD; and Silke Gillessen, MD, explore advancing care for your mCRPC patients with life-prolonging therapies, including the latest findings from the PEACE III trial. Also be sure to obtain your CE credit! #PeerVoice #meded #oncology #prostatecancer #mCRPC

Watch Now: https://lnkd.in/epRcCk-2 When considering later-line therapy for metastatic colorectal cancer (mCRC), how can real-world evidence shape management strategies? Join the experts in a new CE peer-to-peer video discussion as they explore how recent outcomes can help individualise mCRC care.  #PeerVoice #meded #oncology #mCRC #colorectalcancer

Register to attend our upcoming CE-accredited webcast: peervoice.com/Virtual-gMG Join this CE-Accredited Live Webcast to explore emerging evidence associated with novel therapies for the individualised management of generalised myasthenia gravis.

Watch Now: https://lnkd.in/eb6wV7sY In this two-part activity, Professor Karin Jordan and Dr Erika Hamilton discuss strategies for preventing and controlling emesis in patients receiving antibody-drug conjugates who are more prone to nausea and those with comorbidities.  #PeerVoice #oncology #CE #CINV #antiemesis #AntibodyDrugConjugates #ADCs